Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells

Bioengineered Bugs

Volumn 1, Issue 6, 2010, Pages

  Geletneky, Karsten ^a,b   Hartkopf, Andreas D ^c   Krempien, Robert ^d   Rommelaere, Jean ^b   Schlehofer, Joerg R ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d HELIOS Klinikum Berlin   (Germany)

Author keywords

Combination therapy; Malignant glioma; Oncolytic virus; Parvovirus H 1; Radiation therapy; Stem cells

Indexed keywords

ARTICLE; AUTOPHAGY; CANCER SUSCEPTIBILITY; CELL KILLING; CELL SURVIVAL; CELL VIABILITY; CYTOTOXICITY; GLIOMA CELL; H-1 PARVOVIRUS; HUMAN; IONIZING RADIATION; ONCOLYTIC VIROTHERAPY; PARVOVIRUS INFECTION; RADIATION DOSE; THERAPY EFFECT; VIRUS REPLICATION; BRAIN TUMOR; GLIOMA; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; TUMOR CELL CULTURE; VIROLOGY;

H-1 PARVOVIRUS;

ONCOLYTIC VIRUS;

BRAIN NEOPLASMS; CELL SURVIVAL; COMBINED MODALITY THERAPY; GLIOMA; H-1 PARVOVIRUS; HUMANS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; TUMOR CELLS, CULTURED;

EID: 78650191743     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bbug.1.6.12943     Document Type: Article

References (16)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352:987-96.
2. Zemp FJ, Corredor JC, Lun X, Muruve DA, Forsyth PA. Oncolytic viruses as experimental treatments for malignant gliomas: Using a scourge to treat a devil. Cytokine Growth Factor Rev 2010.
3. Aghi M, Martuza RL. Oncolytic viral therapies-the clinical experience. Oncogene 2005; 24:7802-16.
4. Advani SJ, Mezhir JJ, Roizman B, Weichselbaum RR. ReVOLT: radiation-enhanced viral oncolytic therapy. Int J Radiat Oncol Biol Phys 2006; 66:637-46.
5. Rommelaere J, Geletneky K, Angelova AL, Daeffler L, Dinsart C, Kiprianova I, et al. Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev 2010.
6. Herrero YCM, Cornelis JJ, Herold-Mende C, Rommelaere J, Schlehofer JR, Geletneky K. Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. Int J Cancer 2004; 109:76-84.
7. Di Piazza M, Mader C, Geletneky K, Herrero YCM, Weber E, Schlehofer J, et al. Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells. J Virol 2007; 81:4186-98.
8. Geletneky K, Kiprianova I, Ayache A, Koch R, Herrero YCM, Deleu L, et al. Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models. Neuro Oncol 2010.
9. Wolter S, Richards R, Armentrout RW. Cell cycledependent replication of the DNA of minute virus of mice, a parvovirus. Biochim Biophys Acta 1980; 607:420-31.
10. Zhou XD, Wang XY, Qu FJ, Zhong YH, Lu XD, Zhao P, et al. Detection of cancer stem cells from the C6 glioma cell line. J Int Med Res 2009; 37:503-10.
11. Kelly SE, Di Benedetto A, Greco A, Howard CM, Sollars VE, Primerano DA, et al. Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One 2010; 5:10035.
12. Zhou ZH, Ping YF, Yu SC, Yi L, Yao XH, Chen JH, et al. A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. Cancer Lett 2009; 281:92-9.
13. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60.
14. Chalmers AJ. Radioresistant glioma stem cells-therapeutic obstacle or promising target? DNA Repair (Amst) 2007; 6:1391-4.
15. Kang MK, Hur BI, Ko MH, Kim CH, Cha SH, Kang SK. Potential identity of multi-potential cancer stemlike subpopulation after radiation of cultured brain glioma. BMC Neurosci 2008; 9:15.
16. Combs SE, Debus J, Schulz-Ertner D. Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer 2007; 7:167.